(SIG) Signet Jewelers - Overview
Stock: Diamond Jewelry, Engagement Rings, Watches, Earrings, Bracelets
| Risk 5d forecast | |
|---|---|
| Volatility | 48.4% |
| Relative Tail Risk | -11.3% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.44 |
| Alpha | 55.13 |
| Character TTM | |
|---|---|
| Beta | 1.627 |
| Beta Downside | 1.481 |
| Drawdowns 3y | |
|---|---|
| Max DD | 57.12% |
| CAGR/Max DD | 0.20 |
EPS (Earnings per Share)
Revenue
Description: SIG Signet Jewelers March 01, 2026
Signet Jewelers Ltd (NYSE: SIG) is the world’s largest specialty retailer of diamond jewelry, operating through three segments: North America, International, and Other. The North America segment runs a mix of mall-based, kiosk, and off-mall stores under brands such as Kay, Zales, Jared, James Allen, and Blue Nile, while the International segment focuses on the U.K. and Ireland with H. Samuel and Ernest Jones. The “Other” segment purchases rough diamonds, polishes them, and provides diamond-processing services.
In its most recent fiscal year (2024), Signet generated $7.3 billion in revenue, a 3.2% increase YoY, with adjusted earnings per share of $1.45. Same-store sales in the North America segment rose 4.8%, and online sales accelerated 15% year-over-year, driven by the continued integration of James Allen and Blue Nile platforms.
Key economic drivers include a modest rebound in U.S. consumer confidence (index ≈ 102) and stable discretionary spending despite a 5.25% Fed funds rate, which keeps financing costs for high-ticket items like engagement rings elevated. Additionally, the global diamond price index has risen about 3% in 2024 as supply constraints tighten, supporting margin expansion for the company’s polishing operations.
For a deeper dive into SIG’s valuation and outlook, consider exploring the analysis on ValueRay.
Headlines to watch out for
- Consumer discretionary spending impacts jewelry demand
- Diamond prices influence cost of goods sold
- E-commerce growth affects store sales
- North American segment drives majority of revenue
Piotroski VR‑10 (Strict, 0-10) 8.0
| Net Income: 145.0m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.11 > 0.02 and ΔFCF/TA 3.68 > 1.0 |
| NWC/Revenue: 12.51% < 20% (prev 13.21%; Δ -0.69% < -1%) |
| CFO/TA 0.13 > 3% & CFO 722.7m > Net Income 145.0m |
| Net Debt (1.78b) to EBITDA (613.9m): 2.89 < 3 |
| Current Ratio: 1.50 > 1.5 & < 3 |
| Outstanding Shares: last quarter (41.2m) vs 12m ago -7.83% < -2% |
| Gross Margin: 39.75% > 18% (prev 0.40%; Δ 3935 % > 0.5%) |
| Asset Turnover: 122.9% > 50% (prev 120.5%; Δ 2.48% > 0%) |
| Interest Coverage Ratio: 1164 > 6 (EBITDA TTM 613.9m / Interest Expense TTM 400.0k) |
Altman Z'' 4.86
| A: 0.16 (Total Current Assets 2.57b - Total Current Liabilities 1.71b) / Total Assets 5.41b |
| B: 0.69 (Retained Earnings 3.75b / Total Assets 5.41b) |
| C: 0.08 (EBIT TTM 465.4m / Avg Total Assets 5.55b) |
| D: 0.95 (Book Value of Equity 3.51b / Total Liabilities 3.69b) |
| Altman-Z'' Score: 4.86 = AA |
Beneish M -3.56
| DSRI: 0.60 (Receivables 42.4m/70.7m, Revenue 6.82b/6.85b) |
| GMI: 0.99 (GM 39.75% / 39.51%) |
| AQI: 0.84 (AQ_t 0.24 / AQ_t-1 0.28) |
| SGI: 1.00 (Revenue 6.82b / 6.85b) |
| TATA: -0.11 (NI 145.0m - CFO 722.7m) / TA 5.41b) |
| Beneish M-Score: -3.56 (Cap -4..+1) = AAA |
What is the price of SIG shares?
Over the past week, the price has changed by -6.51%, over one month by -0.84%, over three months by -1.62% and over the past year by +91.52%.
Is SIG a buy, sell or hold?
- StrongBuy: 2
- Buy: 1
- Hold: 4
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the SIG price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 112.2 | 23.6% |
| Analysts Target Price | 112.2 | 23.6% |
SIG Fundamental Data Overview March 07, 2026
P/E Forward = 9.0334
P/S = 0.5626
P/B = 2.2626
P/EG = 2.3994
Revenue TTM = 6.82b USD
EBIT TTM = 465.4m USD
EBITDA TTM = 613.9m USD
Long Term Debt = 1.15b USD (from capitalLeaseObligations, last quarter)
Short Term Debt = 293.8m USD (from shortTermDebt, last quarter)
Debt = 2.01b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 1.78b USD (from netDebt column, last quarter)
Enterprise Value = 5.61b USD (3.84b + Debt 2.01b - CCE 234.7m)
Interest Coverage Ratio = 1164 (Ebit TTM 465.4m / Interest Expense TTM 400.0k)
EV/FCF = 9.50x (Enterprise Value 5.61b / FCF TTM 591.0m)
FCF Yield = 10.53% (FCF TTM 591.0m / Enterprise Value 5.61b)
FCF Margin = 8.66% (FCF TTM 591.0m / Revenue TTM 6.82b)
Net Margin = 2.13% (Net Income TTM 145.0m / Revenue TTM 6.82b)
Gross Margin = 39.75% ((Revenue TTM 6.82b - Cost of Revenue TTM 4.11b) / Revenue TTM)
Gross Margin QoQ = 37.28% (prev 38.56%)
Tobins Q-Ratio = 1.04 (Enterprise Value 5.61b / Total Assets 5.41b)
Interest Expense / Debt = 0.00% (Interest Expense 100.0k / Debt 2.01b)
Taxrate = 20.63% (5.20m / 25.2m)
NOPAT = 369.4m (EBIT 465.4m * (1 - 20.63%))
Current Ratio = 1.50 (Total Current Assets 2.57b / Total Current Liabilities 1.71b)
Debt / Equity = 1.17 (Debt 2.01b / totalStockholderEquity, last quarter 1.72b)
Debt / EBITDA = 2.89 (Net Debt 1.78b / EBITDA 613.9m)
Debt / FCF = 3.01 (Net Debt 1.78b / FCF TTM 591.0m)
Total Stockholder Equity = 1.77b (last 4 quarters mean from totalStockholderEquity)
RoA = 2.61% (Net Income 145.0m / Total Assets 5.41b)
RoE = 8.20% (Net Income TTM 145.0m / Total Stockholder Equity 1.77b)
RoCE = 15.93% (EBIT 465.4m / Capital Employed (Equity 1.77b + L.T.Debt 1.15b))
RoIC = 20.88% (NOPAT 369.4m / Invested Capital 1.77b)
WACC = 7.82% (E(3.84b)/V(5.85b) * Re(11.91%) + D(2.01b)/V(5.85b) * Rd(0.00%) * (1-Tc(0.21)))
Discount Rate = 11.91% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -4.95%
[DCF] Terminal Value 77.49% ; FCFF base≈519.4m ; Y1≈476.9m ; Y5≈425.8m
[DCF] Fair Price = 150.4 (EV 7.89b - Net Debt 1.78b = Equity 6.12b / Shares 40.7m; r=7.82% [WACC]; 5y FCF grow -10.24% → 2.90% )
EPS Correlation: -36.79 | EPS CAGR: -55.84% | SUE: -4.0 | # QB: 0
Revenue Correlation: -45.35 | Revenue CAGR: -17.10% | SUE: 0.86 | # QB: 4
EPS next Quarter (2026-04-30): EPS=1.41 | Chg7d=+0.032 | Chg30d=+0.034 | Revisions Net=+1 | Analysts=8
EPS next Year (2027-01-31): EPS=10.48 | Chg7d=+0.077 | Chg30d=-0.023 | Revisions Net=+1 | Growth EPS=+12.7% | Growth Revenue=+1.4%
[Analyst] Revisions Ratio: +0.33 (2 Up / 1 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 8.4% (Discount Rate 11.9% - Earnings Yield 3.5%)
[Growth] Growth Spread = -7.5% (Analyst 1.0% - Implied 8.4%)